NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 430 filers reported holding NOVAVAX INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $345,000 | +28.3% | 6,703 | +83.3% | 0.00% | 0.0% |
| Q1 2022 | $269,000 | -49.1% | 3,656 | -1.2% | 0.00% | -50.0% |
| Q4 2021 | $529,000 | -0.6% | 3,700 | +44.1% | 0.00% | 0.0% |
| Q3 2021 | $532,000 | +300.0% | 2,567 | +310.7% | 0.00% | +300.0% |
| Q2 2021 | $133,000 | +20.9% | 625 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | +378.3% | 609 | +190.0% | 0.00% | – |
| Q4 2020 | $23,000 | +21.1% | 210 | +14.8% | 0.00% | – |
| Q3 2020 | $19,000 | +5.6% | 183 | -16.8% | 0.00% | – |
| Q2 2020 | $18,000 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |